Francesca Barone's most recent trade in Candel Therapeutics Inc was a trade of 4,282 Common Stock done at an average price of $4.7 . Disclosure was reported to the exchange on June 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 4.67 per share. | 25 Jun 2025 | 4,282 | 100,809 | - | 4.7 | 19,997 | Common Stock |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.76 per share. | 18 Mar 2025 | 32,146 | 96,527 | - | 8.8 | 281,673 | Common Stock |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.55 per share. | 18 Mar 2025 | 18,000 | 128,673 | - | 1.6 | 27,900 | Common Stock |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2025 | 18,000 | 30,822 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 15 Jan 2025 | 13,534 | 110,673 | - | 7.2 | 97,783 | Common Stock |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 4.56 per share. | 29 Nov 2024 | 22,081 | 137,880 | - | 4.6 | 100,592 | Common Stock |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 17 Jul 2024 | 14,051 | 159,961 | - | 6.5 | 90,947 | Common Stock |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 5.97 per share. | 11 Jul 2024 | 12,645 | 174,012 | - | 6.0 | 75,534 | Common Stock |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 90,000 | 90,000 | - | - | Stock Option (Right to Biuy) | |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 1.61 per share. | 08 Dec 2022 | 1,238 | 2,738 | - | 1.6 | 1,993 | Common Stock |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Nov 2022 | 90,877 | 92,377 | - | 0 | Common Stock | |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Francesca Barone | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) |